REGN
Regeneron Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$672.15-0.67%
Price as of Jul 20, 2026
REGN valuation
Regeneron Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 13.32x
- P/E 2026E
- 14.98x
- P/E 2027E
- 12.89x
- P/E 2028E
- 11.20x
- P/S forward
- 4.13x
Trailing multiples
- P/E TTM
- 15.80x
- PEG TTM
- 0.86x
- Price / book
- 2.24x
- Price / sales
- 4.72x
- Price / cash flow
- 14.06x
Enterprise value
- Enterprise value
- $64.4B
- EV / sales
- 4.32x
- EV / EBITDA
- 11.21x
- EV / EBIT
- 17.75x
- Market cap
- $70.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.